JPRN-jRCTs041180131已完成2 期
Phase two clinical trial of limited stage lymphoblastic lymphoma. - LLB-NHL03
Sekimizu Masahiro0 个研究点目标入组 48 人开始时间: 2019年3月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 至 < 18age old（—）
- 性别
- All
入选标准
- •Newly diagnosed patients with limited T and B cell lymphoblastic lymphoma
排除标准
- •1, Down's syndrome
- •2, previous malignancy of any type
- •3, Prior stem cell or organ transplantation
- •4, Congenital or acquired immunodeficiency
研究者
相似试验
招募中
2 期
Phase two clinical trial of limited stage lymphoblastic lymphoma.JPRN-UMIN000002213Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)42
已完成
2 期
Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative StudyAdvanced stage lymphoblastic lymphoma of children.JPRN-UMIN000002212Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)124
进行中（未招募）
不适用
Experimental study in humans to evaluate the efficacy and safety of blood products rich in proteins for the treatment of anal fistulas in Crohn's patients without subsidiary drug treatment.Perianal fistulas in Crohn's Disease PatientsMedDRA version: 14.1Level: PTClassification code 10002156Term: Anal fistulaSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-006127-38-ESFundación FISEVI
进行中（未招募）
不适用
Experimental study in humans to evaluate the efficacy and safety of bloodproducts rich in proteins for the treatment of anal fistulas in Crohn'spatientsPerianal fistulas in Crohn's Disease PatientsMedDRA version: 14.1Level: LLTClassification code 10068659Term: Perianal fistulaSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-004820-37-ESFundación FISEVI
进行中（未招募）
不适用
An Open-label Phase 2 Study in Patients with Asymptomatic Multiple MyelomaSmoldering (asymptomatic) multiple myelomaMedDRA version: 14.1Level: PTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-004884-29-SEBioInvent International AB10